Enzolytics Inc (ENZC)

[falon]

ENZC is not a pump and dump stock.

What is a pump and dump stock?

Typically a pump and dump scam occurs when fraudsters boost the company's stock price by sharing positive, but fake, information. Scammers buy up the shares cheap before spreading the rumors that drive the stock price higher and higher and encourage other investors to get in on the supposed windfall.

There is NOTHING FAKE about ENZC!!!

Why ENZC is not a pump and dump stock?

1. They are PINK current on the OTC, filed financial reports and paid money
to do so.

2. They spent money to file patents.

3. The spent money to hire a PCOAB auditor to audit financials from 2019 and 2020.

4. ENZC spent money to have toxicity tests done.

5. ENZC spent money to have AI analysis to to identify conserved epitopes.

6. ENZC spent money to conduct an in vitro study of the Company's ITV-1/IPF peptide treatment that demonstrated the broad efficacy with low toxicity.

7. ENZC spent money to produce monoclonal antibodies.

8. ENZC spent money to lease laboratory space at Texas A&M.

pump and dump stocks SURELY don't spent money on ACTVITIES that ENZC has.

As a a RESULT of these ACITVUTIES by ENZC we are waiting for the following INFORMATION:



FACTS we KNOW:

1. AI

2. Monoclonal Antibodies being produced

3. Toxicity study results imminent

4. 19+ Patents

5. 2020 Annual Report imminent

6. PCOAB for 2019 and 2020 expected next month

7. The application for OTCQB is being prepared for submission upon issuance of the Audited Statements

8. Charles is in Charge

What we don't know:

1. Relationship to Gileads?

2. Relationship to Eli Lily?

3. Relationship to Immunome?

4. Acquisition?

ENZC has used AI to advance/expedite the production of Monoclonal Antibodies.
ENZC is still at the ground floor with the foundation set, the cornerstone in place and is building a solid company that will rival, challenge and change the landscape of the pharmaceutical world in a way that has never be seen before.


Enzolytics continues its onward and upward march towards strategic partnerships and a stronger Intellectual Property portfolio.


#ENZC #HIV #COVID19 #AI #Gileads #EliLilly #Patent #Monoclonal #Antibodies #acquisition #partnership #immunome

The Company is actively progressing to produce monoclonal antibodies against many other viruses. The proprietary methodically used by the Company will be employed to produce monoclonal antibodies against numerous other virus and using "AI", the Company is curating the know sequences of the following viruses and intends to both seek patent coverage and produce monoclonal antibodies targeting conserved sequences These viruses include:

HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV) and Visna virus (VISNA). Patent applications will be filed claiming the inventive findings. Patent claims will cover the discovered epitope/antigens, with proposed vaccine claims, antibody claims, and related prophylactic/therapeutic method claims relating to these identified epitope/antigens.

FACTS not fiction

1. A PR CAN'T EVEN GET THE PRICE UP. WRONG

Press Releases do not drive up stock prices, RESULTS from the company does.

2. IT'S NOW A SELL THE NEWS DEAL AFTER THAT PR. WRONG

For TRADERS/FLIPPERS only!!! Long term holders will hold their shares for better returns.

3. NO OTHER GREAT NEWS IS COMING ANY TIME SOON. WRONG

Yea right that is a figment of your imagination.

There is no LIMIT for ENZC stock price appreciation!!!

Too much going on with ENZC.

The company could drop press release any time that WILL send the stock past all previous HIGHS!


4. WITH NO GREAT NEWS COMING, PEOPLE WILL LOSE INTEREST AND MOVE TO THE NEXT PLAY. WRONG

LONG TERM HOLDERS are here to stay waiting for and will get their DOLLAR price ranges.

5. TOO MANY UNSECURED NOTES. WRONG

Those too many UNSECURED NOTES was here when ENZC ran to over 90 CENTS and will be here when ENZC runs to DOLLARS!!!

6. NO PROOF OF ANY SHARES BEING LOCKED UP. WRONG

The Company has also negotiated a debt exchange whereby most of the existing convertible debt has been exchanged for equity instruments that have a two-year conversion clause to postpone conversions for the next two years. We believe this step, along with the reorganization under Section 251 G that was initiated prior to the closing of the combination agreement, will significantly enhance the equity position of the Company.
https://marketwirenews.com/news-releases/enzolytics-inc-2020-year-end-update-6713954951124293.html

7. THE DAILY CHART SHOWS A DOWN TREND WITH LOWER LOWS. WRONG

Charts are not DRIVING ENZC CHARLES is!!!

8. 1,584,725,795 – 1.584 BILLION UNRESTRICTED SHARES WRONG

ENZC SECURITY DETAILS
Share Structure
Market Cap Market Cap
1,076,925,548
03/09/2021
Authorized Shares
3,000,000,000
02/28/2021
Outstanding Shares
2,797,935,953
02/28/2021
Restricted
735,839,585
02/28/2021
Unrestricted
2,062,096,368
02/28/2021
Held at DTC
1,770,323,548
02/28/2021
Float
1,670,830,512
09/30/2020

9. THEY WON'T UPDATE THE FLOAT! WRONG

The FLOAT will be updated in near future when the 2020 annual is released.